Have you read this JDD consensus on advanced topical nonsteroidal therapies for atopic dermatitis? Dive into this recent article from the March issue! A seven-dermatologist expert panel used a structured…
Read More
Have you read this JDD consensus on advanced topical nonsteroidal therapies for atopic dermatitis? A recent retrospective analysis using the TriNetX research network compared patients with non scarring hair loss…
Read More
GLP-1 Receptor Agonist Use and Hidradenitis Suppurativa in Overweight Patients — Retrospective Findings from a Single Center Have you read this article in the latest JDD issue? A recent IRB-exempt…
Read More
From the Vault: In this article from JDD, a multi state BRFSS analysis finds higher skin cancer history in rural populations and In this article from the JDD vault, authors…
Read More
Have you read this JDD case report on combination therapy for dissecting cellulitis of the scalp? Have you read this article in JDD? This case report describes two men, ages…
Read More
Check out our all-new JDD Video Abstract from Benjamin Ungar MD, who discusses Molecular Insights: Immune and Barrier Dysregulation in Seborrheic Dermatitis.
Read More
JDD study on biologics and cardiometabolic Dive into this March article! A large retrospective analysis using the TriNetX research network examined adults with hidradenitis suppurativa who were treated with biologics…
Read More
Check Out JDD Corner’s Latest Author Spotlight Our current Author Spotlight features David Ciocon MD, one of the co-authors of “Racial Disparities in Un ited States Clinical Trial Enrollment for…
Read More
From the Vault: Noninvasive RNA from Tape Strips Differentiates AK from SCC In this article from the JDD vault, authors report a single center study that used adhesive tape strips…
Read More
A comparative evaluation finds promising concordance but highlights gaps that require In the February JDD, authors compared two large language models, ChatGPT and DeepSeek, against the 2021 American Academy of…
Read More
Retrospective JDD study finds minocycline or doxycycline (100 mg twice daily) led to meaningful improvement in inflammatory gingival OLP in two months In a recent JDD report of 254 biopsy‑confirmed…
Read More
Lilly published the results of a Phase 3b clinical trial that showed treatment with concomitant Taltz (ixekizumab) and Zepbound (tirzepatide) was superior to ixekizumab alone in patients with active psoriatic…
Read More
